Conventional pulse oximeters typically alarm based on large and isolated drops in oxygen saturation values, known as a "desaturation". However, published research has shown that a cycle of moderate desaturations has been shown to precede respiratory failure in hospitalized patients.1, 2 Masimo Desat Index 3D Alarm enables advanced notification of these conditions, based on clinician-specified severity and number of desaturations occurring in a specified period of time... Masimo's Press Release -
Blog Archive
-
▼
2008
(297)
-
▼
September
(17)
- Masimo : Desaturation Index 3D Alarm as Standard F...
- Pharmaxis : Second Pivotal Phase 3 Trial In Cystic...
- Simcere Pharmaceutical : Interim Results of Endu P...
- Oncolytics Biotech : U.S. Phase 2 Combination Clin...
- Forest Laboratories and Almirall : Phase III Clini...
- Boehringer Ingelheim & Pfizer : Established Safety...
- Wyeth Pharmaceuticals : Major Adult Vaccine Clinic...
- Cystic fibrosis : Axentis Pharma Initiates Clinica...
- MERCK SERONO SUBMITS NEW LICENSE APPLICATION FOR E...
- Tianyin Pharmaceutical : Chinese SFDA Approval for...
- Compugen : Peptide Drug Candidate for Treatment of...
- Aeris Therapeutics : Phase 2 Trial Results for Non...
- Draeger Medical Extends Its Partnership with Inten...
- Orexo : clinical phase II program for OX914 - a n...
- Discovery Labs : Aerosolized KL-4 Surfactant Selec...
- Idera Pharmaceuticals : Milestone Payment Under As...
- ImClone Systems : ERBITUX(R) Phase 3 BMS-099 Lung ...
-
▼
September
(17)
Sep 25, 2008
Masimo : Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices
September 10, 2008 – Masimo (NASDAQ: MASI), the inventor of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion pulse oximetry, announced that all customers purchasing the Masimo Radical-7, the company's flagship product, will now receive Desat Index 3D Alarm as a standard feature.